Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett Doble

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
BMJ Open|June 7, 2019
Comprehensive ascertainment of bleeding in patients prescribed different combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study protocol for three population-based cohort studies emulating 'target trials' (the ADAPTT Study)Maria Pufulete, Jessica Harris, Jonathan A C Sterne, et al.
Health Technology Assessment (Winchester, England)|July 12, 2023
Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studiesJessica Harris, Koen B Pouwels, Thomas Johnson, et al.
BMJ Open|May 1, 2020
Clinical and cost-effectiveness of a diabetes education and behavioural weight management programme versus a diabetes education programme in adults with a recent diagnosis of type 2 diabetes: study protocol for the Glucose Lowering through Weight management (GLoW) randomised controlled trialAmy L Ahern, Jenny Woolston, Emma Wells, et al.
Journal of Personalized Medicine|November 4, 2015
"Cancer 2015": A Prospective, Population-Based Cancer Cohort-Phase 1: Feasibility of Genomics-Guided Precision Medicine in the ClinicJohn P Parisot, Heather Thorne, Andrew Fellowes, et al.
Lancet (London, England)|February 3, 2022
Report of the Lancet Commission on the Value of Death: bringing death back into lifeLibby Sallnow, Richard Smith, Sam H Ahmedzai, et al.
Lung Cancer (Amsterdam, Netherlands)|December 14, 2019
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysisAaron C Tan, Gillianne G Y Lai, Gek San Tan, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
BMJ Open|June 7, 2019
Comprehensive ascertainment of bleeding in patients prescribed different combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study protocol for three population-based cohort studies emulating 'target trials' (the ADAPTT Study)Maria Pufulete, Jessica Harris, Jonathan A C Sterne, et al.
Health Technology Assessment (Winchester, England)|July 12, 2023
Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studiesJessica Harris, Koen B Pouwels, Thomas Johnson, et al.
BMJ Open|May 1, 2020
Clinical and cost-effectiveness of a diabetes education and behavioural weight management programme versus a diabetes education programme in adults with a recent diagnosis of type 2 diabetes: study protocol for the Glucose Lowering through Weight management (GLoW) randomised controlled trialAmy L Ahern, Jenny Woolston, Emma Wells, et al.
Journal of Personalized Medicine|November 4, 2015
"Cancer 2015": A Prospective, Population-Based Cancer Cohort-Phase 1: Feasibility of Genomics-Guided Precision Medicine in the ClinicJohn P Parisot, Heather Thorne, Andrew Fellowes, et al.
Lancet (London, England)|February 3, 2022
Report of the Lancet Commission on the Value of Death: bringing death back into lifeLibby Sallnow, Richard Smith, Sam H Ahmedzai, et al.
Lung Cancer (Amsterdam, Netherlands)|December 14, 2019
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysisAaron C Tan, Gillianne G Y Lai, Gek San Tan, et al.
Pageof 5